Internal Medicine, Pulmonary Disease · Fredericksburg, VA
NPI
1548259823
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
521 Park Hill Dr
Fredericksburg, VA, 22401
Phone (540) 899-1615
Groups this clinician bills Medicare through
Medicare paid, 2024
$796K
17,287 services
Medicare patients, 2024
1,901
Average age 75
Drug cost, 2024
$1.2M
3,231 prescriptions
Company payments, 2025
$13K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey R Rehm was code J2182 (injection, mepolizumab, 1 mg), 3,700 times for 12 patients. In total Jeffrey R Rehm billed 17,287 services in 55 codes, and Medicare paid $796K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2182 Injection, mepolizumab, 1 mg | Office | 3,700 | 12 | $23.87 | $88K |
| 99214 Office E&M - Established | Office | 1,757 | 911 | $91.66 | $161K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,589 | 446 | $45.55 | $72K |
| 99491 Chronic, Principal, and Transitional Care Management | Office | 942 | 301 | $64.57 | $61K |
| 99213 Office E&M - Established | Office | 927 | 619 | $63.27 | $59K |
| 99232 Hospital E&M - Subsequent | Facility | 581 | 222 | $59.67 | $35K |
| 94060 Pulmonary Function Testing | Office | 471 | 460 | $28.11 | $13K |
| 94729 Pulmonary Function Testing | Office | 466 | 456 | $40.78 | $19K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 397 | 210 | $36.29 | $14K |
| 94726 Pulmonary Function Testing | Office | 326 | 319 | $40.13 | $13K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 206 | 91 | $101.79 | $21K |
| 94618 Pulmonary Function Testing | Office | 192 | 170 | $25.26 | $4,849 |
| 93922 Duplex Scan - Extremity Arteries | Office | 161 | 97 | $62.77 | $10K |
| 99203 Office E&M - New | Office | 156 | 156 | $72.94 | $11K |
| 96401 Chemotherapy Administration | Office | 152 | 42 | $52.98 | $8,053 |
By year: 2022 $273K for 4,011 services; 2023 $360K for 5,747 services; 2024 $796K for 17,287 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey R Rehm prescribed most often to Medicare patients was Ipratropium Bromide, with 620 prescriptions and refills. In total Jeffrey R Rehm wrote 3,231 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 620 | 1,228 | 281 | $28K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 457 | 602 | 198 | $13K |
| Fluticasone Propionate Generic | 455 | 1,024 | 217 | $8,579 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 218 | 352 | 74 | $222K |
| Breo Ellipta Fluticasone/Vilanterol | 140 | 202 | 40 | $79K |
| Varenicline Tartrate Generic | 119 | 206 | 58 | $35K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 115 | 170 | 33 | $70K |
| Prednisone Generic | 109 | 111 | 54 | $235 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 100 | 173 | 29 | $79K |
| Spiriva Respimat Tiotropium Bromide | 71 | 136 | 25 | $70K |
| Montelukast Sodium Generic | 67 | 147 | 26 | $612 |
| Symbicort Budesonide/Formoterol Fumarate | 60 | 108 | 19 | $24K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 56 | 112 | 29 | $70K |
| Ventolin Hfa Albuterol Sulfate | 32 | 35 | Under 11 | $1,990 |
| Losartan Potassium Generic | 28 | 54 | 11 | $283 |
Brand drugs: 1,293 claims; generic drugs: 1,938 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey R Rehm $13K ($13K in general payments such as food, travel and fees) from 30 companies. The largest payer was United Therapeutics Corporation with $6,629.
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation UTHR | 19 | $6,629 |
| Inspire Medical Systems, Inc. INSP | 9 | $1,033 |
| AstraZeneca Pharmaceuticals LP AZN | 27 | $931 |
| GlaxoSmithKline, LLC. GSK | 24 | $544 |
| Mallinckrodt Hospital Products Inc. | 8 | $361 |
| ANI Pharmaceuticals, Inc. ANIP | 11 | $350 |
| Shionogi Inc 4507.T | 25 | $332 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $292 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $280 |
| Actelion Pharmaceuticals US, Inc. JNJ | 9 | $255 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.